Insider Transactions in Q1 2025 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,407
-6.26%
|
$182,932
$76.43 P/Share
|
|
Feb 25
2025
|
Waleed H Hassanein President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
59,781
+32.99%
|
-
|
|
Feb 24
2025
|
Gerardo Hernandez Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,521
+18.05%
|
-
|
|
Feb 24
2025
|
Anil P. Ranganath |
BUY
Grant, award, or other acquisition
|
Direct |
5,634
+27.79%
|
-
|
|
Feb 24
2025
|
Nicholas Corcoran |
BUY
Grant, award, or other acquisition
|
Direct |
12,676
+27.29%
|
-
|
|
Feb 24
2025
|
Tamer I Khayal Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,606
+31.41%
|
-
|
|
Jan 07
2025
|
Tamer I Khayal Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,083
-4.94%
|
$86,640
$80.05 P/Share
|
|
Jan 07
2025
|
Tamer I Khayal Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,083
+4.71%
|
$14,079
$13.28 P/Share
|